fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Menopause and migraines: New findings point to power of prevention

Written by | 19 Feb 2024

For middle-aged women plagued by migraines, or hot flashes and night sweats, another worry may linger in the backs of their minds: whether these experiences have set them… read more.

How ovarian tissue freezing could prevent menopause—possibly forever

Written by | 13 Feb 2024

Most women agree that menopause has its advantages and disadvantages. Some relish the end of menstruation and concerns about unplanned pregnancies, while others dread the possibililty of hot… read more.

MHRA approves Veoza (fezolinetant) to treat vasomotor symptoms associated with menopause – Astellas

Written by | 23 Dec 2023

Veoza (Veozah in the US), also known as fezolinetant, from Astellas, has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) after receiving similar approval in… read more.

European Commission approves Veoza (fezolinetant) to treat vasomotor symptoms associated with menopause – Astellas

Written by | 18 Dec 2023

Astellas Pharma Inc. announced the European Commission (EC) on December 7 approved Veoza (fezolinetant) 45 mg once daily for the treatment of moderate to severe vasomotor symptoms (VMS)… read more.

Age at menopause could determine risk for decline in muscle mass and strength

Written by | 3 Dec 2023

A shorter reproductive life span, which is determined by a woman’s age at menarche and menopause, has been associated with a number of adverse health effects, including cardiovascular… read more.

Calls for improved support about menstruation changes during perimenopause

Written by | 23 Nov 2023

Perimenopausal women need better education and support about how their periods might change towards the end of their reproductive life, finds a new study led by UCL researchers…. read more.

Landmark menopause toolkit updated to improve assessment and treatment

Written by | 3 Nov 2023

Care for women with menopausal health issues should improve globally following the release of an updated Monash University-led toolkit that guides health professionals around the world in assessing… read more.

CHMP positive for Vezoa (fezolinetant) to treat vasomotor symptoms associated with menopause – Astellas Pharma

Written by | 23 Oct 2023

Astellas Pharma Inc. announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) on October 12 adopted a positive opinion relating to… read more.

Obese women have worse menopause symptoms and get less relief from hormone therapy

Written by | 28 Sep 2023

Obesity has already been associated with a number of adverse health conditions and can interfere with a person’s quality of life. A new study suggests that, in addition… read more.

OB/Gyn residency programs should offer more menopause training

Written by | 3 Sep 2023

A nationwide assessment of Obstetrics and Gynecology residency programs reveals the need for more training in how to provide the best care for women going through menopause, according… read more.

Plans for UK’s first menopause education programme launched by UCL academics

Written by | 22 Aug 2023

Experts at UCL have teamed up with leading women’s health charities to design a new education and support programme for women across the country experiencing menopause. The National… read more.

New survey confirms need for more menopause education in residency programs

Written by | 16 Aug 2023

Despite the fact that nearly 90 million women in the United States are projected to be postmenopausal by 2060, menopause remains low on the priority list of many… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.